155 related articles for article (PubMed ID: 8958187)
1. Exploitation of folate and antifolate polyglutamylation to achieve selective anticancer chemotherapy.
McGuire JJ; Tsukamoto T; Hart BP; Coward JK; Kalman TI; Galivan J
Invest New Drugs; 1996; 14(3):317-23. PubMed ID: 8958187
[TBL] [Abstract][Full Text] [Related]
2. Loss of folylpoly-gamma-glutamate synthetase activity is a dominant mechanism of resistance to polyglutamylation-dependent novel antifolates in multiple human leukemia sublines.
Liani E; Rothem L; Bunni MA; Smith CA; Jansen G; Assaraf YG
Int J Cancer; 2003 Feb; 103(5):587-99. PubMed ID: 12494465
[TBL] [Abstract][Full Text] [Related]
3. Folylpoly-γ-glutamate synthetase: A key determinant of folate homeostasis and antifolate resistance in cancer.
Raz S; Stark M; Assaraf YG
Drug Resist Updat; 2016 Sep; 28():43-64. PubMed ID: 27620954
[TBL] [Abstract][Full Text] [Related]
4. Mechanism-based approaches to inhibition of the synthesis and degradation of folate and antifolate polyglutamates.
Kalman TI
Adv Exp Med Biol; 1993; 338():639-43. PubMed ID: 7508172
[No Abstract] [Full Text] [Related]
5. Molecular basis of antifolate resistance.
Assaraf YG
Cancer Metastasis Rev; 2007 Mar; 26(1):153-81. PubMed ID: 17333344
[TBL] [Abstract][Full Text] [Related]
6. Recent advances in the chemistry and biology of folypoly-gamma-glutamate synthetase substrates and inhibitors.
Gangjee A; Dubash NP; Zeng Y; McGuire JJ
Curr Med Chem Anticancer Agents; 2002 May; 2(3):331-55. PubMed ID: 12678736
[TBL] [Abstract][Full Text] [Related]
7. Anticancer antifolates: current status and future directions.
McGuire JJ
Curr Pharm Des; 2003; 9(31):2593-613. PubMed ID: 14529544
[TBL] [Abstract][Full Text] [Related]
8. DL-beta,beta-difluoroglutamic acid mediates position-dependent enhancement or termination of pteroylpoly(gamma-glutamate) synthesis catalyzed by folylpolyglutamate synthetase.
McGuire JJ; Hart BP; Haile WH; Rhee MS; Galivan J; Coward JK
Arch Biochem Biophys; 1995 Aug; 321(2):319-28. PubMed ID: 7646057
[TBL] [Abstract][Full Text] [Related]
9. Methotrexate analogues. 26. Inhibition of dihydrofolate reductase and folylpolyglutamate synthetase activity and in vitro tumor cell growth by methotrexate and aminopterin analogues containing a basic amino acid side chain.
Rosowsky A; Freisheim JH; Moran RG; Solan VC; Bader H; Wright JE; Radike-Smith M
J Med Chem; 1986 May; 29(5):655-60. PubMed ID: 2871191
[TBL] [Abstract][Full Text] [Related]
10. Multiple folate enzyme inhibition: mechanism of a novel pyrrolopyrimidine-based antifolate LY231514 (MTA).
Shih C; Habeck LL; Mendelsohn LG; Chen VJ; Schultz RM
Adv Enzyme Regul; 1998; 38():135-52. PubMed ID: 9762351
[TBL] [Abstract][Full Text] [Related]
11. Recent advances in the understanding of the mechanism of membrane transport of folates and antifolates.
Sierra EE; Goldman ID
Semin Oncol; 1999 Apr; 26(2 Suppl 6):11-23. PubMed ID: 10598550
[TBL] [Abstract][Full Text] [Related]
12. Folate analog nonsubstrates and inhibitors of folylpolyglutamate synthetase as potential cancer chemotherapy drugs.
McGuire JJ; Piper JR; Coward JK; Galivan J
NCI Monogr; 1987; (5):139-44. PubMed ID: 2448652
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and biologic activity of new side-chain-altered methotrexate and aminopterin analogs with dual inhibitory action against dihydrofolate reductase and folylpolyglutamate synthetase.
Rosowsky A; Moran RG; Freisheim JH; Bader H; Forsch RA; Solan VC
NCI Monogr; 1987; (5):145-52. PubMed ID: 3431589
[TBL] [Abstract][Full Text] [Related]
14. Aberrant splicing of folylpolyglutamate synthetase as a novel mechanism of antifolate resistance in leukemia.
Stark M; Wichman C; Avivi I; Assaraf YG
Blood; 2009 Apr; 113(18):4362-9. PubMed ID: 19131550
[TBL] [Abstract][Full Text] [Related]
15. Folylpoly-gamma-glutamate synthetase: generation of isozymes and the role in one carbon metabolism and antifolate cytotoxicity.
Qi H; Atkinson I; Xiao S; Choi YJ; Tobimatsu T; Shane B
Adv Enzyme Regul; 1999; 39():263-73. PubMed ID: 10470377
[TBL] [Abstract][Full Text] [Related]
16. Quinazoline thymidylate synthase inhibitors: methods for assessing the contribution of polyglutamation to their in vitro activity.
Jackman AL; Kimbell R; Brown M; Brunton L; Boyle FT
Anticancer Drug Des; 1995 Oct; 10(7):555-72. PubMed ID: 7495479
[TBL] [Abstract][Full Text] [Related]
17. Effect of polyglutamylation of methotrexate on its accumulation and the development of resistance in the protozoan parasite Leishmania.
El-Fadili A; Richard D; Kündig C; Ouellette M
Biochem Pharmacol; 2003 Sep; 66(6):999-1008. PubMed ID: 12963486
[TBL] [Abstract][Full Text] [Related]
18. Mechanism-based inhibition of human folylpolyglutamate synthetase: design, synthesis, and biochemical characterization of a phosphapeptide mimic of the tetrahedral intermediate.
Tsukamoto T; Haile WH; McGuire JJ; Coward JK
Arch Biochem Biophys; 1998 Jul; 355(1):109-18. PubMed ID: 9647673
[TBL] [Abstract][Full Text] [Related]
19. Thymidylate synthase level as the main predictive parameter for sensitivity to 5-fluorouracil, but not for folate-based thymidylate synthase inhibitors, in 13 nonselected colon cancer cell lines.
van Triest B; Pinedo HM; van Hensbergen Y; Smid K; Telleman F; Schoenmakers PS; van der Wilt CL; van Laar JA; Noordhuis P; Jansen G; Peters GJ
Clin Cancer Res; 1999 Mar; 5(3):643-54. PubMed ID: 10100718
[TBL] [Abstract][Full Text] [Related]
20. Effects of folate and folylpolyglutamyl synthase modulation on chemosensitivity of breast cancer cells.
Cho RC; Cole PD; Sohn KJ; Gaisano G; Croxford R; Kamen BA; Kim YI
Mol Cancer Ther; 2007 Nov; 6(11):2909-20. PubMed ID: 18025275
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]